1. Home
  2. CYCU vs RNXT Comparison

CYCU vs RNXT Comparison

Compare CYCU & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cycurion Inc.

CYCU

Cycurion Inc.

HOLD

Current Price

$3.32

Market Cap

94.8M

Sector

N/A

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$1.70

Market Cap

79.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYCU
RNXT
Founded
2017
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.8M
79.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CYCU
RNXT
Price
$3.32
$1.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$7.00
$8.25
AVG Volume (30 Days)
1.3M
1.4M
Earning Date
06-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
$17,771,485.00
$1,123,000.00
Revenue This Year
$8.92
$194.66
Revenue Next Year
$10.00
$279.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$0.16
$0.70
52 Week High
$7.13
$2.59

Technical Indicators

Market Signals
Indicator
CYCU
RNXT
Relative Strength Index (RSI) 66.85 51.22
Support Level $0.66 $0.83
Resistance Level $4.30 $2.59
Average True Range (ATR) 0.34 0.26
MACD -0.03 -0.07
Stochastic Oscillator 48.32 13.46

Price Performance

Historical Comparison
CYCU
RNXT

About CYCU Cycurion Inc.

Cycurion Inc. provides information technology security solutions through its subsidiaries. The company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company has one reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: